[SGYP] Synergy Pharmaceuticals, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 5.77 Change: 1.03 (21.73%)
Ext. hours: 5.75 Change: -0.02 (-0.35%)

chart SGYP

Refresh chart

Strongest Trends Summary For SGYP

SGYP is in the medium-term up 253% in 3 weeks and down -87% in 4 months and down -88% below S&P in 1 year. In the long-term down -96% below S&P in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders, as well as is in Phase IIb clinical trials for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company also develops SP-333, which is in Phase II clinical trials to treat GI inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-54.85% ROE432.02% ROI
Current Ratio9.53 Quick Ratio Long Term Debt/Equity1.23 Debt Ratio-0.77
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities5.41 M Cash From Investing Activities-50.01 M Cash From Operating Activities-23.15 M Gross Profit
Net Profit-27.39 M Operating Profit-22.8 M Total Assets194.83 M Total Current Assets182.28 M
Total Current Liabilities19.13 M Total Debt200 M Total Liabilities219.57 M Total Revenue
Technical Data
High 52 week2.64 Low 52 week0.08 Last close0.09 Last change-18.15%
RSI16.15 Average true range0.05 Beta0.78 Volume31.45 M
Simple moving average 20 days-71.25% Simple moving average 50 days-86.2% Simple moving average 200 days-94.19%
Performance Data
Performance Week-45.88% Performance Month-77.91% Performance Quart-94.94% Performance Half-95.8%
Performance Year-95.67% Performance Year-to-date-96.12% Volatility daily21.8% Volatility weekly48.74%
Volatility monthly99.88% Volatility yearly346.01% Relative Volume577.63% Average Volume8.71 M
New High New Low

News

2019-01-09 08:03:43 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.

2019-01-07 10:46:20 | [$$] Charlotte Russe Reassesses Its Future, Including Sale or Bankruptcy

2019-01-04 17:52:13 | [$$] Synergy Pharmaceuticals Wins Court Approval for Extended Sale Process

2019-01-04 10:10:00 | These 4 Healthcare Stocks Are Making Moves

2019-01-02 11:55:00 | These 4 Healthcare Stocks Are Kicking Off The New Year With A Bang

2018-12-31 08:59:00 | 4 Pharma Stocks Gaining Speed on Monday 12/31/18

2018-12-28 13:33:17 | [$$] Firm Retention Summary: Synergy Pharmaceuticals Inc.

2018-12-21 10:45:00 | These 4 Pharma Stocks Could Test December Highs

2018-12-20 08:02:09 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.

2018-12-19 12:30:00 | These 4 Pharma Stocks Are Heating Up

2018-12-18 06:50:00 | Today's Research Reports on Trending Tickers: Achillion Pharmaceuticals and Synergy Pharmaceuticals

2018-12-18 06:40:00 | 4 Stocks to Watch Pre-Market on Tuesday 12/18/2018

2018-12-17 13:30:00 | 4 Stocks Providing Investor Opportunity Right Now

2018-12-17 10:33:22 | [$$] Neiman Marcus Asks Court to Dismiss Lawsuit by Marble Ridge

2018-12-17 07:00:00 | Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada

2018-12-14 13:50:14 | [$$] Synergy Pharmaceuticals Kicks Off Path Toward Sale

2018-12-13 09:02:02 | Bausch BHC Bids for Assets of Synergy Pharmaceuticals

2018-12-13 06:55:00 | Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Synergy Pharmaceuticals

2018-12-12 13:21:16 | No Emoji Could Hide This Drugmaker’s Woes

2018-12-12 12:36:14 | Synergy Pharmaceuticals Bankruptcy: SGYP Stock Plummets on Filing

2018-12-12 10:40:33 | [$$] Former Pharma Highflier Appreciates Bathroom Humor

2018-12-12 09:36:07 | [$$] Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million

2018-12-12 07:43:00 | UPDATE: Synergy Pharma shares slide 55% as it files for Chapter 11, clearing way for sale too Bausch

2018-12-12 07:30:00 | Synergy Pharma shares slide 29% as it files for Chapter 11, clearing way for sale too Bausch

2018-12-12 06:30:00 | Bausch Health Enters Into Definitive _Stalking Horse_ Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc.

2018-12-12 06:00:00 | Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets

2018-12-06 08:02:23 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.

2018-11-24 08:03:52 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.

2018-11-13 08:25:00 | Recent Analysis Shows Brown Forman, CryoLife, Aspen Group, Taylor Devices, Synergy Pharmaceuticals, and Ramco-Gershenson Properties Trust Market Influences — Renewed Outlook, Key Drivers of Growth

2018-11-13 08:02:39 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.

2018-11-08 20:30:01 | Synergy Pharmaceuticals SGYP Reports Q3 Loss, Misses Revenue Estimates

2018-11-08 19:26:07 | Synergy Pharma: 3Q Earnings Snapshot

2018-11-08 17:00:00 | Synergy Pharmaceuticals Reports Third Quarter 2018 Financial Results and Business Update

2018-11-02 10:49:24 | What We Can Learn From Synergy Pharmaceuticals' Disastrous News

2018-11-01 20:21:00 | Scary Markets, Frightening Stocks, and How to Keep From Panicking

2018-10-31 17:00:00 | Synergy Pharmaceuticals Names Dr. Melvin K. Spigelman Chairman

2018-10-26 16:55:45 | Why Synergy Pharmaceuticals, Tesla, Tencent and More Are Trending

2018-10-26 10:45:26 | [$$] Investors Frown on Biotech Famed for Emojis

2018-10-26 10:45:00 | Why Synergy Pharmaceuticals Is Being Obliterated Today

2018-10-25 17:00:00 | Synergy Pharmaceuticals Provides Business Update

2018-10-08 08:00:00 | Synergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® plecanatide in Two Patient Populations at the American College of Gastroenterology ACG Annual Scientific Meeting

2018-10-03 09:41:01 | Is the Options Market Predicting a Spike in Synergy Pharmaceuticals SGYP Stock?

2018-10-01 09:30:00 | Synergy Pharmaceuticals to Present New Analyses of TRULANCE® Plecanatide at the American College of Gastroenterology ACG Annual Scientific Meeting

2018-09-24 08:00:00 | Synergy Pharmaceuticals Strengthens Coverage for TRULANCE® plecanatide with Key New Market Access Wins

2018-09-19 15:03:00 | Shareholders Should Check If Insiders Own Shares In Synergy Pharmaceuticals Inc NASDAQ:SGYP

2018-09-15 08:04:01 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.

2018-09-11 09:12:00 | Here's Why Synergy Pharmaceuticals Rose 14.1% in August

2018-08-31 08:46:12 | Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals SGYP Stock?

2018-08-31 08:00:00 | Market Trends Toward New Normal in Sykes Enterprises, Carnival, Covenant Transportation Group, Synergy Pharmaceuticals, Regeneron Pharmaceuticals, and Minerals Technologies — Emerging Consolidated Expectations, Analyst Ratings

2018-08-23 08:07:06 | See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc.